Literature DB >> 26134333

Scoring Systems for Outcome Prediction in a Cardiac Surgical Intensive Care Unit: A Comparative Study.

Themistocles Exarchopoulos1, Efstratia Charitidou2, Panagiotis Dedeilias2, Christos Charitos2, Christina Routsi2.   

Abstract

BACKGROUND: Most scoring systems used to predict clinical outcome in critical care were not designed for application in cardiac surgery patients.
OBJECTIVES: To compare the predictive ability of the most widely used scoring systems (Acute Physiology and Chronic Health Evaluation [APACHE] II, Simplified Acute Physiology Score [SAPS] II, and Sequential Organ Failure Assessment [SOFA]) and of 2 specialized systems (European System for Cardiac Operative Risk Evaluation [EuroSCORE] II and the cardiac surgery score [CASUS]) for clinical outcome in patients after cardiac surgery.
METHODS: Consecutive patients admitted to a cardiac surgical intensive care unit (CSICU) were prospectively studied. Data on the preoperative condition, intraoperative parameters, and postoperative course were collected. EuroSCORE II, CASUS, and scores from 3 general severity-scoring systems (APACHE II, SAPS II, and SOFA) were calculated on the first postoperative day. Clinical outcome was defined as 30-day mortality and in-hospital morbidity.
RESULTS: A total of 150 patients were included. Thirty-day mortality was 6%. CASUS was superior in outcome prediction, both in relation to discrimination (area under curve, 0.89) and calibration (Brier score = 0.043, χ(2) = 2.2, P = .89), followed by EuroSCORE II for 30-day mortality (area under curve, 0.87) and SOFA for morbidity (Spearman ρ= 0.37 and 0.35 for the CSICU length of stay and duration of mechanical ventilation, respectively; Wilcoxon W = 367.5, P = .03 for probability of readmission to CSICU).
CONCLUSIONS: CASUS can be recommended as the most reliable and beneficial option for benchmarking and risk stratification in cardiac surgery patients. ©2015 American Association of Critical-Care Nurses.

Entities:  

Mesh:

Year:  2015        PMID: 26134333     DOI: 10.4037/ajcc2015500

Source DB:  PubMed          Journal:  Am J Crit Care        ISSN: 1062-3264            Impact factor:   2.228


  5 in total

1.  Predictive Factors of Long-Term Stay in the ICU after Cardiac Surgery: Logistic CASUS Score, Serum Bilirubin Dosage and Extracorporeal Circulation Time.

Authors:  Marcio Fernandes Pimentel; Marcelo José Ferreira Soares; Jamil Alli Murad; Marcos Aurelio Barboza de Oliveira; Fernanda Luiza Faria; Vinicius Zani Faveri; Yuzo Iano; Rodrigo Capobianco Guido
Journal:  Braz J Cardiovasc Surg       Date:  2017 Sep-Oct

2.  The APACHE II Score as a Predictor of Mortality After Open Heart Surgery.

Authors:  Mihriban Yalçın; Eda Gödekmerdan; Kaptanıderya Tayfur; Serkan Yazman; Melih Ürkmez; Yusuf Ata
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-09-12

3.  Endogenous Ouabain: An Old Cardiotonic Steroid as a New Biomarker of Heart Failure and a Predictor of Mortality after Cardiac Surgery.

Authors:  Marco Simonini; Simona Pozzoli; Elena Bignami; Nunzia Casamassima; Elisabetta Messaggio; Chiara Lanzani; Elena Frati; Irene Maria Botticelli; Francesco Rotatori; Ottavio Alfieri; Alberto Zangrillo; Paolo Manunta
Journal:  Biomed Res Int       Date:  2015-11-01       Impact factor: 3.411

4.  Reintubation of patients submitted to cardiac surgery: a retrospective analysis.

Authors:  Cíntia Yukie Shoji; Luciana Castilho de Figuereido; Eveline Maria Calixtre; Cristiane Delgado Alves Rodrigues; Antonio Luis Eiras Falcão; Pedro Paulo Martins; Ana Paula Ragonete Dos Anjos; Desanka Dragosavac
Journal:  Rev Bras Ter Intensiva       Date:  2017 Apr-Jun

5.  Performance of Severity Indices to Estimate Postoperative Complications of Myocardial Revascularization.

Authors:  Silvana Alves Dos Santos Franzotti; Dyenily Alessi Sloboda; Juliana Rosendo Silva; Ellian Amorim Santos Souza; Jessica Zamora Reboreda; Renata Eloah de Lucena Ferretti-Rebustini; Lilia de Souza Nogueira
Journal:  Arq Bras Cardiol       Date:  2020-09       Impact factor: 2.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.